NAT10 and cancer: The half maximal inhibitory concentration (IC50) values revealed a selective effect of NAT10‐2023 on cancer cell viability, with significantly lower IC50 values for SK‐HEP‐1 and HCCLM3 compared to LX2 and HEK293, suggesting a strong tumor‐targeting capability (Figure 8A).